Using NALM6-luc as an in vivo xenogeneic leukemia model, NSG-IL15 mice were injected intravenously with leukemia cells and treated the following day with a single intravenous dose of CIMLNK and followed by intraperitoneal injections of TAFA. This evidence concerns the gene IL15 and leukemia.